Alzheimer disease-presenilin pathway | •1) | • |
Angiogenesis | • | |
Apoptosis signaling pathway | | • |
ATP synthesis | • | • |
Cadherin signaling pathway | • | • |
Cholecystokinin receptor signaling map | • | • |
Cytoskeletal regulation by Rho GTPase | • | • |
De novo purine biosynthesis | • | • |
De novo pyrimidine deoxyribonucleotide biosynthesis | • | • |
De novo pyrimidine ribonucleotides biosynthesis | • | • |
Dopamine receptor mediated signaling pathway | • | |
Epidermal growth factor receptor signaling pathway | • | • |
Fibroblast growth factor signaling pathway | • | • |
Fructose galactose metabolism | | • |
Glycolysis | • | • |
Gonadotropin-releasing hormone receptor pathway | • | • |
Huntington disease | • | • |
Integrin signaling pathway | • | • |
Nicotine pharmacodynamics pathway | • | |
p38 mitogen-activated protein kinase pathway | • | |
p53 pathway | • | • |
Parkinson disease | • | • |
Pentose phosphate pathway | • | |
PI3 kinase pathway | | • |
Salvage pyrimidine ribonucleotides | • | • |
Vascular endothelial growth factor signaling pathway | • | |
Wnt signaling pathway | • | • |